🇺🇸 FDA
Patent

US 9884076

Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy

granted A61KA61K35/00A61K35/34

Quick answer

US patent 9884076 (Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy) held by Capricor, Inc. expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Capricor, Inc.
Grant date
Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K35/00, A61K35/34, A61P, A61P9/00